BioXcel Therapeutics
BTAI
BTAI
43 hedge funds and large institutions have $63.3M invested in BioXcel Therapeutics in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
18
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$5.85M |
| 2 |
DAM
DLD Asset Management
New York
|
$956K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$3.73M |
| 4 |
BFM
Boothbay Fund Management
New York
|
$384K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
$281K |
